Showing results (321-330 of 346) with videos related to
Sort By:
Pageof 35
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2019
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched AnalysisAnkur Varma, Dawen Sui, Denái R Milton, et al.Blood Advances|July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicityUri Greenbaum, Paolo Strati, Rima M Saliba, et al.Nature Reviews. Clinical Oncology|August 8, 2018
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapyKris M Mahadeo, Sajad J Khazal, Hisham Abdel-Azim, et al.Nature Medicine|January 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trialDavid Marin, Ye Li, Rafet Basar, et al.Blood|March 18, 2015
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantationUday Popat, Rohtesh S Mehta, Katayoun Rezvani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2024
Randomized Phase III SIERRA Trial of <sup>131</sup>I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AMLBoglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, et al.The Journal of Clinical Investigation|August 3, 2016
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cellsPartow Kebriaei, Harjeet Singh, M Helen Huls, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2021
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following AllotransplantationAmanda Olson, Ruitao Lin, David Marin, et al.Cancer Immunology Research|May 12, 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic CancerApostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson, et al.Transplantation and Cellular Therapy|April 27, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell LymphomaRoni Shouval, Christopher Strouse, Soyoung Kim, et al.Pageof 35